Spinal Cord Stimulation Market Size, Share and Industry Analysis By Product (Implantable Pulse Generator, Radiofrequency System), By Disease Indication (Failed Back Syndrome, Degenerative Disk Disease, Complex Regional Pain Syndrome, Arachnoiditis), By End Users (Hospital, Ambulatory Surgical Centers, Specialty Clinics), and Regional Forecast 2020-2029 (Includes COVID-19 Business Impact)

                                          
We have updated Spinal Cord Stimulation Market with respect to COVID-19 Business Impact.
Inquire before buying


This report focuses on the Spinal Cord Stimulation market and value at the global level, regional level, and company level. From a global perspective, this report represents the overall Spinal Cord Stimulation market size by analyzing historical data and future prospects. Regionally, this report focuses on several key regions: North America, Europe, Japan, China, Southeast Asia, India, Latin America, and South America.


Global Spinal Cord Stimulation Market: Segment Analysis


The research report includes specific segments by region (country), by Company, by Type, and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2019 to 2029. An in-depth analysis of the segments assists in identifying the different factors that will aid market growth.


Global Spinal Cord Stimulation Market: Regional Analysis


The research report includes a detailed study of regions of North America, Europe, Japan, China, Southeast Asia, India, Latin America, and South America. The report has been curated after observing and studying various factors that determine regional growth such as the economic, environmental, social, technological, and political status of the particular region. Researchers have studied the data of revenue, sales, and manufacturers of each mentioned region. This section analyses region-wise revenue and volume for the forecast period of 2019 to 2029.


Global Spinal Cord Stimulation Market: Competitive Landscape


This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2019 to 2029.
List of Companies Profiled

  
Medtronic
  
Abbott
  
Boston Scientific Corporation
  
Stimwave LLC
  
Nevro Corp.
  
Nuvectra
  
Other players

Report Coverage

Spinal cord stimulation is one of the neuromodulation technique in which electrical impulses are delivered to the spinal cord in order to mask the pain signal. The introduction of MRI conditional spinal cord stimulators, favorable health reimbursement, emerging government guidelines, and positive recommendations are the major factors for the increased demand for spinal cord stimulation therapy. Also, the significant reduction in the intake of opioid medications has increased the preference for spinal cord stimulators among the patients.

The report provides qualitative and quantitative insights on the spinal cord stimulation industry and detailed analysis of market size and growth rate for all possible segments in the market. The market is segmented by product type, disease indication, and end-user. Based on the product, the global spinal cord stimulation market is segmented into the implantable pulse generator and radiofrequency system. The implantable pulse generator segment can be further classified into rechargeable and non-rechargeable. In terms of disease indication, the market is categorized into Failed Back Syndrome (FBS), Degenerative Disk Disease (DDD), Complex Regional Pain Syndrome (CRPS), arachnoiditis, and others.

Various end-users covered under the report are hospitals, ambulatory surgical centers, and specialty clinics. Geographically, the market is segmented into five major regions, which are North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The regions are further categorized into countries.

Along with this, the report provides an elaborative analysis of the market dynamics and competitive landscape. Various key insights provided in the report are the prevalence of chronic back pain for key countries, new product launch, the regulatory scenario for key countries, global reimbursement overview, recent industry developments such as mergers & acquisitions and key industry trends.

SEGMENTATION

By Product

  
Implantable Pulse Generator
  
Rechargeable
  
Non-rechargeable
  
Radiofrequency System

By Disease Indication

  
Failed Back Syndrome (FBS)
  
Degenerative Disk Disease (DDD)
  
Complex Regional Pain Syndrome (CRPS)
  
Arachnoiditis
  
Others

By End User

  
Hospital
  
Ambulatory Surgical Centers
  
Specialty Clinics

By Geography

  
North America (USA and Canada)
  
Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
  
Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
  
Latin America (Brazil, Mexico and Rest of Latin America)
  
Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)

Key Industry Developments

In September 2019, Abbott announced the USFDA approval of PROCLAIM XR, a recharge-free neurostimulation system for treatment of patients with chronic pain.

In January 2019, Boston Scientific launched SPECTRA WAVEWRITER spinal cord stimulator system in Europe. The system is used for treatment against chronic pain and debilitating pain.

In August 2018, Nevro Corp. received USFDA approval for next-generation SENZA II Spinal Cord Stimulation (SCS) System used to deliver HF10 therapy.